Schedule a Call
King-Devick technologies, inc.

King-Devick technologies, inc.

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

 

 

Book a Conference Call
Get More Information

King-Devick technologies, inc.

Location: Oakbrook Terrace, Illinois

Sector: Technology, Software, Health, Life Sciences

Add to Shortlist
Express Interest

King-Devick technologies, inc. (KDT) offers a broad set of evidence-based SaaS model tools utilizing integrated technology for concussion management, balance evaluation, reading solutions and as indicators of neurological function for chronic neuro-degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, MS, migraine headaches, sleep deprivation, hypoxia and macular degeneration.

 

King-Devick products have been scientifically validated in more than 150 recent peer-reviewed articles published in elite medical journals. In 2015, Mayo Clinic and King-Devick Test announced a co-branding licensing agreement for the sideline concussion test – now recognized as the King-Devick Test in association with Mayo Clinic.

 

For more information, please visit: www.kingdevick.com.

1. Co-Branded with the number one health care provider/hospital in the United States,  Mayo Clinic

The King-Devick Test in association with Mayo Clinic is utilized on rinksides, sidelines and pitchsides all over the world including all players and teams in the National Hockey League and Canadian Football League and many other teams, leagues and schools.

 

2. More than 150 peer-reviewed articles published in elite neurology journals have validated our products over the last 6 years

Using an evidence-based approach has resulted in unsurpassed credibility related to our product releases.  Every product we have has been validated by independent research before we go to market with it.

 

3. We have three business verticals with a total addressable 12 Billion USD Total Addressable Market annually in a SaaS Model of sales

Our business verticals are:

  • Concussion Management – sideline screening and clinical management of recovery
  • Neurological Function – chronic management of neurodegenerative conditions
  • Reading Performance – teaching the physical act of reading in schools to improve reading outcomes.

4. Experienced management with a long history of prior IPO success

CEO Steve Devick has been successful in founding/co-founding several startups to Nasdaq IPOs including a software company (NASDAQ: PLAT) which sold for $3.6 Billion after its IPO.

Doug Laux, CFO has been the CFO of 3 separate companies with over $1B in revenue each including Alamo/National Rental car and has extensive public company management experience.

 

5. Extensive media coverage

KDt has been extensively covered in the national and international press.

 

6. Innovative technology and strong IP

KDt products provide users simplicity and ease of use with clear and objective results for users ranging from parents and coaches to health care providers.

KDt web and mobile applications platforms utilize safe and secure cloud-based technology optimized for telemedicine and includes more than 70 IP registrations in effect including copyright, patents, patents pending, and trademarks registered.

1. Known brand with Mayo Clinic

Mayo Clinic co-branding helps with market recognition all over the world.

 

2. Peer-reviewed established and validated scientific products

Scientifically vetted and validated products which are already in the market

 

3. Experienced management

The CEO, CFO and Board of Directors are extremely experienced in all aspects of successfully completing an Initial Public Offering.

Steve Devick, Chief Executive Officer, President, Chairman

Steve Devick, Chairman and CEO of King-Devick technologies, inc. has been a career entrepreneur. Throughout his tenure in the business world, he has founded multiple successful companies, including the King-Devick technologies, inc., a company that allowed him for the first time to combine his healthcare background with his business acumen.

 

In 2015, Mayo Clinic, for the first time in its 150-year history, executed a co-branding equity contract with an outside company, King-Devick technologies, inc. The sideline screening product is now called the King-Devick Test in association with Mayo Clinic (KDT).

 

In 2017, Dr. Devick, along with Dr. David Dodick, Professor of Neurology at Mayo Clinic, testified before the Senate Armed Service Committee Meeting with an update on research, diagnosis and treatment for traumatic brain injury and concussion in United States Servicemembers. In May, KDt was selected as a winner of the 2017 VA InnoVAtion Awards for its Recovery Acceleration Program; furthering the opportunity to provide rehabilitative technology for Veterans impacted by TBI.

 

In addition to King-Devick technologies, inc., Devick has founded/co-founded a series of successful public and private companies. In 1987, Platinum technology (NASDAQ: PLAT) was co-founded and in 1999 was sold for $3.6 billion-more than any software company had sold for prior to that date.  Devick was also a founding director in Blue Rhino (NASDAQ: RINO), a propane cylinder exchange company in 2004 was sold for over $400M; Devick also founded Platinum Entertainment, which was the world’s largest independent, publicly traded (NASDAQ: PTET) music company.

 

In addition to founding and co-founding multiple businesses, Devick also produced a feature length film, Head Games: The Global Concussion Crisis, which addressed the epidemic of concussions in sports, and was directed by Academy Award honored Steve James. Head Games won Best Documentary at the Boston Film Festival and many other awards including Best Sports Documentary from both Sports Illustrated and iTunes.

 

Devick was recognized by Crain’s Chicago Business as one of the Forty Under Forty business leaders; a regional finalist in Ernst & Young’s Entrepreneur of the Year; New City’s Most Influential People Top 20; and Chairman of the Young Presidents Organization (YPO). He also received the Ernst Jokl Sports Medicine Award from the United States Sports Academy for outstanding sports related medical research. In 2015, the King-Devick Test in association with Mayo Clinic was awarded the Chicago Innovation Award. KDT was selected as a winner from 535 semi-finalists, and 100 finalists. In 2016 Devick received the Innovation of the Year Award from the Concussion Legacy Foundation.  In 2018, the company was listed as a Top 10 Health Care Innovation by the Mayo Clinic.

 

Doug Laux, Chief Financial Officer/Chief Operating Officer, Director

Doug Laux spent the first 20 years of his career with Ernst and Young, the last 9 as a partner in the Chicago office.  Doug has extensive experience with both public and private companies as CFO including ANC Rental Corporation the former $2.5 billion parent of Alamo and National Car Rental Companies, EaglePicher, a $900 million diversified manufacturing company, and Remy International, a $1.3 billion automotive supplier.

 

He was also CFO/COO of Platinum Entertainment Inc., a NASDAQ listed music company he helped take public in 1996.  Doug was also a former director and chairman of the audit committee of Sirva, Inc., the parent of Allied and NorthAmerican Van Lines, prior to its sale and R. J. O’Brien and Associates, the oldest and largest independent futures brokerage and clearing firm in the US.

 

He is also a director of Freeport Securities Company, a family owned oil and gas company. Doug is a graduate of the University of Illinois, with a BS in Accountancy who successfully passed the CPA examination in 1975.

 

Casey Cowell, Director

Mr. Casey Cowell serves as Chairman and Principal Owner of Durandal, Inc.  Mr. Cowell co-founded U.S. Robotics, Inc. in 1976 and served as its Chairman and CEO from 1979 until 1996 when it was merged into 3Com Corp.

 

Mr. Cowell has served as a Director of 3Com Corp., CDW Corp., and many private companies.  Mr. Cowell is a 1975 graduate of the University of Chicago.

 

Jon Cronin, Director

The Cronin Group, LLC is a Boston-based company with its headquarters at Liberty Wharf in Boston’s thriving Seaport District. Led by Principal Jon Cronin, and with over 2000 employees, the group has been developing residential and commercial real estate for over 20 years and is one of the most prominent restaurant developers in Boston.

 

Community involvement and charitable endeavors have been, and continue to be, a core value of The Cronin Group. Mr. Cronin sits on the board of the South Boston Neighborhood House and the South Boston Collaborative Center, as well as being involved with his wife Nicole in many other local charities.

 

David Dodick, MD, Professor of Neurology – Concussions/Sports Medicine, Mayo Clinic

Mr. Dodick serves as Chairman and Member of Medical Advisory Board of Neuralieve Inc. He serves as a Member of Advisory Board at Alder Biopharmaceuticals Inc. Dr. Dodick is co-director of the Annual Scientific Meeting of the American Headache Society and a member of the Scientific Committee of the Migraine Trust.

 

He is a member of the Board of Governors, executive committee, and serves as secretary of the American Headache Society (AHS). He is also the secretary of the Headache & Facial Pain Section of the American Academy of Neurology (AAN), and chairman of Headache and Facial Pain for the Annual AAN meeting. He is associate editor of Cephalalgia and Headache, editor-in-chief of Headache Currents, and on the editorial board for The Neurologist and Postgraduate Medicine.

 

He is the program director of the Mayo Clinic Neurology Residency Program in Scottsdale, Arizona, and co-chair of the AHS Evidence-Based Neurology Training Program in the United States. Dr. Dodick is board certified by both the Royal College of Physicians and Surgeons of Canada, and the American Board of Psychiatry and Neurology.

 

He received his medical degree with distinction from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his internship and neurology residency at the Mayo Clinic in Rochester, Minnesota, followed by fellowships in Headache and Cerebrovascular Diseases at the University of Toronto, in Ontario Canada.

 

Barbara J. Keller – Director, Technology Licensing Manager II, Mayo Clinic Ventures

Mayo Clinic Ventures is dedicated to converting Mayo’s ideas, ingenuity, and expertise into health care products and services.  Before joining Mayo Clinic Ventures, Barb worked as a Contract Manager with Mayo Clinic’s Legal Contract Administration and as an IP Analyst for IBM.

 

Ms. Keller received her B.S.  from Winona State University and her M.A. degree in both Health and Human Service Administration and Management from Saint Mary’s University.

 

Chad Smith – Director, Founder, Liberty Advisor Group

Chad has 29 years of consulting experience with an emphasis on technology strategy, M&A integration, operations improvement, and pricing optimization.  His deep knowledge of technical systems provides clients with solutions for their business and emerging technology concerns that positively impact their top line growth and bottom line profitability.

 

Prior to founding Liberty, Chad worked with Accenture, James Martin, and Co., and led the Consumer-Packaged Goods, Travel and Entertainment Manufacturing & Distribution, Telecommunications, and Government practices at Diamond Management and Technology Consultants. Chad holds a B. A. in Business Administration from Notre Dame University.

 

Robert A. Stern Director, Professor of Neurology, Neurosurgery, and Anatomy and Neurobiology at Boston University School of Medicine where he is also Director of the Clinical Core of the BU Alzheimer’s Disease and CTE Center

Dr. Stern oversees clinical research studies related to Alzheimer’s disease, including clinical trials for the diagnosis, treatment, and prevention of AD.  In addition, his research involves the long-term effects of repetitive head impacts in athletes, including the neurodegenerative disease, CTE.

 

Dr. Stern has received several NIH and other national grants, has over 250 publications, and is a Fellow of both the American Neuropsychiatric Association and the National Academy of Neuropsychology.  His is also the Chair of the Advisory Council to the Medical Scientific Committee of the Massachusetts and New Hampshire Chapter of the Alzheimer’s Association.

 

He is on the Medical Advisory Board of the Concussion Legacy Foundation and is also a member of the Mackey-White Traumatic Brain Injury Committee of the NFL Players Association.


AdviNOW Inc

AdviNOW Inc

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

 

 

 

Book a Conference Call
Get More Information

AdviNow INC

Location: Paradise Valley, AZ

Sector: Health Tech

Add to Shortlist
Express Interest

AdviNow Medical (ANM) completely automates the patient diagnosis and treatment process. Utilizing true artificial intelligence (AI) and augmented reality (AR), ANM collects the required illness information and measurements from the patient and prepares a report for the doctor to enable fast, accurate and efficient patient encounters.

ANM enables an objective physical examination with AR guided objective measurements anywhere at any time while fundamentally reducing the cost to run existing clinics and is a common platform to drive point of care to the home. This automation reduces total provider time-per-patient, improves outcomes and increases patient satisfaction.

The result of the AI enabled documentation is automated care coordination, exact and personal consistency of care, increased patient throughput and reduced patient wait times. This invention promises to revolutionize healthcare for the entire world as every person has access to low-cost affordable care.

1. Comprehensive End to End Medical Office Automation and Patient Management Solution

ANM is the only Artificial Intelligence that completely automates both the patient management, vitals collection and doctor documentation.

 

2. Medical Measurements with Augmented Reality (AR) for complete medical exam

Using state of the art AR, required precision medical measurements can be taken almost anywhere.

 

3. Post Care follow-up and chronic disease management system creates a true closed loop system that continues to learn

Management of the “Whole Patient” enables cost effective population health and the near home health destination in retail outlets

 

4. Discrete Data Collection that can be shared with all interested parties

 Collect data in a discrete format that enables learning for the optimal intervention strategies and automates the closing of care gaps

 

5. EMR integration

Unique technologies that enable Integration into the patients EMR

Patients

  • Near 0 wait time
  • Automated follow-up with Chronic care management
  • Consistent quality
  • Better Outcomes

Doctors

  • 20  5 minutes per patient
  • 3-4 X number of patients per day
  • Burnout significantly reduced with automated documentation
  • Consistency of care reduces liability

Clinics

  • 5X reduction in breakeven → 4 Patient / Day breakeven at retail evidence based clinic
  • 20% cost reduction and 70% wait time reduction for existing clinics
  • Consistent Quality increases patient satisfaction and reduces liability
  • Reduce provider shortage

James Bates, President, and Chief Executive Officer

James is CEO and Founder of ANM. James is a seasoned technology executive with over 20 years of experience inventing and managing the development of revolutionary products while leading companies to “best in class” financial performance. Most recently James ran a $1billion business for Freescale (now NXP Semiconductors) delivering revolutionary self-driving vehicle technologies to auto manufacturers throughout the world.

 

Among his start-up successes is Silicon Labs, where he was the founder of Asian Operations. James built the infrastructure that enabled growth from near $0 to over $300 million in revenue while delivering the technology that shrunk mobile phones to fit in a human hand. James speaks fluent Japanese and holds a master’s degree in electrical engineering from Brigham Young University.

 

Stephen Thompson, Chief Financial Officer

Steve has over 30 years of financial and business management experience, including serving as a partner with Deloitte & Touche LLP, serving as Chief Financial Officer with both public and private companies, and owning and operating an in-home care services business in the Phoenix metro area.

 

His areas of expertise include accounting, finance, internal controls, and risk management. Steve is qualified as a financial expert under Sarbanes-Oxley.

 

 Jim Shelby, Head of Technology

Jim is a seasoned technologist leading digital experience development and management for over 20 years. Prior to joining ANM, Jim was Vice President of Technology with American Express, where he ran multiple organizations in the web engineering organization that serviced millions of customers in over 26 countries.

 

At American Express, Jim led the development of major brand lines such as the Premier Membership Rewards, Small Business Saturday, and the account management of the card platform for consumer and small business customers. Jim holds a bachelor’s in systems and industrial engineering from the University of Arizona and a master’s in business/eCommerce from the University of Phoenix.

 

Chris J. Hill, MHA, FACHE, Chief Marketing Officer

Chris brings a wealth of public and private sector executive hospital and healthcare management experience from his 32 plus years in the healthcare industry. Chris has been the CEO and Regional Vice President of the Arizona Spine and Joint Hospital/Canyon Surgery Center and the St. Luke’s Medical Center/Tempe St. Luke’s Hospital system.

 

In both organizations, he focused on partnering with physicians/providers and introducing innovative technologies to improve healthcare quality and outcomes. Prior to that, as CEO of a tertiary care hospital within the Hospital Corporation of America (HCA) system, he drove technology adoption and unprecedented growth while also improving quality outcomes and the patient experience.

 

Philippe Garre, MS, EIT, Sales & Customer Experience Director

Philippe is Director of Sales and Customer Experience at ANM. He previously worked for the Intel Corporation in global supply chain management where he interfaced with both external customers and internal stakeholders to enable leading-edge semiconductor technology. Philippe completed working for NXP Semiconductors as Senior Automotive Sensor Product and Test Engineer in 2016.

 

Philippe graduated from Gonzaga University as a mechanical engineer where he received a full scholarship to play NCAA Division I men’s soccer. He completed a master’s in Mechanical and Aerospace Engineering from Arizona State University. Philippe speaks fluent Spanish, is Six Sigma certified, and is an EIT.

 

Dr. David Grayson, MD, Medical Director

Dr. Grayson earned his medical degree from Umea University in Sweden. His clinical training then continued at the neurosurgery residency program at Umea University Hospital. During his practice, Dr. Grayson gained deep knowledge in the neuroscience field.

 

He has a special interest in and was fellowship trained in, cerebrovascular and skull base surgery at the Swedish Neuroscience Institute in Seattle, WA. As a full-time faculty member at the neurosurgery department in Umea, his work was continually recognized for improving health outcomes and making healthcare more effective.


Hoy Health

Hoy Health

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information

Hoy Health

Location: Morristown, NJ

Sector: HealthTech.

Add to Shortlist
Express Interest

Empowering the medically under served with innovative cash-based wellness solutions.

The company’s initial products include voucher sales for discount medication, distribution of discount cash-pay cards, chronic care management services and tele-health.

 

Business Documents

MG cp Summary

Hoy Health has launched the following digitally accessible products:

 

HoyRX

The first-of-its-kind medication voucher program that offers patients the ability to pre-purchase affordable generic and select branded medications at $10, $15, $20, $25 redeemable in +62K US pharmacies.  The vouchers can be purchased on our website or directly from your doctor.  Medications can be purchased for yourself, or gifted to a friend or family member either domestically in the US or abroad.

 

HoyMEDS

Hispanic targeted pharmacy discount card that is presented at +62K US pharmacies for cash-pay discounts at the checkout.

 

HoyCCM

Hoy Chronic Conditions Management program is a turnkey end-to-end clinical solution for patients who have diabetes, hypertension, asthma, and obesity.  Includes medications, peripherals, testing supplies, tablet, apps, and coaches.

 

HoyDOC

Bilingual tele-medicine platform connects patients with physicians based in Puerto Rico providing care across the US.

1. Hispanic Focus

Focus on Hispanics (and other cultural groups to follow) provide distinct differentiation and advantage in the market for all of our products.

 

2. Standardized pricing

No other medication voucher program has a fixed price which can be redeemed at any of the pharmacies in our network.  All other programs are only redeemable at a specific pharmacy.

 

3. B2C focus

HoyRX discount medication voucher program can be distributed in 600,000 medical clinics in the US.  All other voucher programs are principally direct to consumer.

 

4. Cross boarder redemption of vouchers

HoyRX is the first medication voucher program that allows family members to purchase medication in the US and have them delivered to their family members in Mexico and Latin America ($1.5bn corridor for medications annually).

 

5. Retail partnerships

Growing number of retail partnerships that have provided (i) distribution (ii) marketing support (iii) preferential pharmacy pricing

Mario Anglada, CEO

Healthcare executive, with deep experience in Hispanic and Latin American outreach and marketing, pharmaceuticals, Over the counter products, and medical devices. Mario has 23 years in healthcare sales and marketing, developed first Hispanic medication discount program, pediatric vitamin line, telemedicine line, and diabetes peer mentoring program. Mario hold an MBA from of Science from University of Phoenix, Puerto Rico.

 

Arlene RodriguezCOO

Arlena has 15 years operational experience at in telehealth, customer service and medical supplies. Previous to Hoy Health, Arlena held significant positions at Sentry Data Systems, MDLIVE, Liberty Medical Supply and Medco Health Solutions, VP of Operations. She attended Florida Atlantic University for BS Finance and holds an MBA from Nova Southeastern University.

 

Josh Neumann, CFO

Josh has 20 years of experience in finance, venture capital, capital markets and management consulting. His experience is across companies like Pacific Capital Group, HSBC in Specialist Investments and PricewaterhouseCoopers in Management Consulting. Josh attended UC Berkeley, Haas School of Business for his Bachelor degree in  Business Administration and MBA from UCLA Anderson School of Business.

 

Patrick Todd, CRO

Patrick has 18 years experience in CPG and healthcare marketing, healthcare professional medical detailing, new business/channel development, international brand launches. He worked at Nestle Nutrition North America (Gerber) as the VP Head of New Business Development and Nestle Health Science as the VP Marketing, Consumer Care Retail. Patrick holds BA Economics from University of Chicago and MBA from University of Southern California, Marshall School of Business.

 

Co-Founder, CTO

Jose has 25 years of healthcare and IT experience in programming, IT project management, and IT consulting. He worked with NTT Data Services, Intelligroup and Empower Solutions as a Project Manager. Jose holds a Bachelor of Science in Computer Science from Universidad de Puerto Rico.

 

Ilan Shapiro, Chief Medical Officer

Previous to Hoy Helath, Ilan was  Medical Director at AltaMed and Head of Wellness & Innovation West Region Co-Chair at NHMA (National Hispanic Medical Association). Ilan attended Universidad Anahuac for MD Medicine and holds Certificate in Business Foundations from UCLA Anderson School of Management.


LyfeUp Inc

LyfeUp Inc

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information

LyfeUp Inc.

Location: Oakville, ON

Sector: Health .

Add to Shortlist
Express Interest

LyfeUp is a personalized health concierge, powered by Artificial Intelligence (AI), built on Blockchain technology to streamline health information including diagnostic test results.

It manages access and storage of the member’s health-related information, understands the member’s current health status, predicts potential health risks, and adjusts their lifestyle for optimum wellness.

Business Documents

MG cp Summary

LyfeUp offers you a highly secure and convenient, personalized health concierge. It uses Artificial Intelligence to understand your current health status and adjust your lifestyle for optimum wellness. LyfeUp’s Concierge helps you follow your custom lifestyle plan, designed and monitored by our experts, all through a text, voice and video enabled intelligent and automated chat interface, to achieve your goals, 24/7. You can request on-demand video calls with our network of health practitioners, or even order our optional at-home lab kits, diagnosing your body’s Genetics, Hormones, Micronutrients and much more.

 

LyfeUp is backed by a partner-owned clinic in Ontario (Canada), giving it the ability to offer its international services thru partner health practitioners.

 

LyfeUp Concierge

The Chatbot (Concierge), thru its interactive on-boarding process, does an initial assessment for you, to understand your current lifestyle.

 

Then you will receive a Biometrics Package, which includes a digital scale and activity tracker pre-connected to the subscriber’s profile, allowing them to automatically log their progress without manual entry.

 

The concierge will also recommend optional at-home diagnostic lab kits for a more detailed holistic view of your body. If lab kits were ordered, follow the instructions to take a sample (saliva, dry blood, dry urine) in the comfort of your home and return it by mail to our certified partner labs for analysis. Subscribers receive special discount on the kits, although you can request them without being a LyfeUp Concierge member at a premium.

 

Finally, our experts will setup a lifestyle plan for you on the system, and if requested, a one-on-one consultation is available.

 

The Chatbot (Concierge) will then work with you to follow your lifestyle plan, 24/7, embedding those test results to personalize the advice. Lifestyle advice includes meal planning (food to eat, and if needed cooking recipes), exercises and other helpful recommendations.

 

LyfeUp Services

Our services are split into Addons (which we provide directly), and Partners services provided by 3rd parties.
The addons include: Intervention where our specialists (physicians, dietitians and others) can provide one-on-one consultations, on demand thru video calls. This service allows our network of participating health practitioners to grow their patients (LyfeUp becomes a patient acquisition channel), while the Concierge takes care of routine followups on their designed lifestyle plans, to make their services much more effective.

 

We also have a special Diabetes program for those diagnosed with Type II Diabetes as they require specialized care.
And finally, through partnerships with world renowned supplements manufacturers, our system would recommend customized nutraceutical formulas to complement and improve our subscribers’ wellness, which we will ship to their door.

 

For 3rd party partners’ services, this includes: Surgery (where we refer patients in need of Bariatric or Balloon (Endoscopy) surgeries to our partner surgeons and hospitals in various jurisdictions), programs to deliver meals based on their diet, and Personal Trainers providing discounts for our subscribers.

Management

LyfeUp’s founding team brings diverse skills including: engineering, medical, franchising and financing. They have prior founded and scaled successful ventures into IPOs (NASDAQ). Collectively, the founders and their leading ventures have been featured by various leading media outlets and publications, including: Harvard Business Review, MIT Enterprise Forum, The New York Times, and others.

 

Hadi Aladdin,Co-founder & CEO

Hadi Aladdin is a serial entrepreneur, engineer, and published author. Being a coder since the age of 11, he has founded and  grew successful technology ventures with global reach, including: CoursePeer Inc., ArabCode.org, Kula Technologies Inc.,  Angstron Technologies Inc. and others, spanning the fields of education technology, food ordering technology, software  development consulting and Hyperloop (transportation).

 

The University of Toronto has recognized Hadi among its top researchers in its Annual Research Report. Hadi has played a  vital role in establishing the startup incubation system at the University of Toronto, and he acts as an active founding mentor  and judge at the “Entrepreneurship Hatchery” – the formal incubator of the Faculty of Applied Science and Engineering at the University of Toronto.

 

Hadi’s work has been featured at various reputable publications, including the Harvard Business Review, Deloitte reports, and  Dubai School of Government’s Social Media report, and his ventures have been endorsed by government and business  leaders such as Justin Trudeau (Canada’s Prime Minister), Omar Hamoui (Investment Partner at Sequoia Capital; Former  President, Mobile Ads at Google Inc.; Founder of AdMob), Fadi Ghandour (Founder of ARAMEX and Executive Chairman of  Wamda Capital), Ahmad Al Shugairi (activist and media figure in the Middle East), Ilse Treurnicht (CEO of MaRS Discovery  District), and Majed Al Suwaidi (Managing Director of Dubai Internet City and Dubai Outsource Zone).

 

Hadi has been invited as a speaker at various international conferences including the MIT Enterprise Forum, The Annual  Conference of the Higher Education Quality Council of Ontario and the IEEE Young Professionals. He is a frequent judge and  mentor at various regional and international incubators and competitions including: Startup Weekend, RIC Centre, ICUBE  UTM, Humber College, in5 (Dubai Internet City incubator), TURN8, Smart City App Hack and “The Hatchery“.

 

Education: Bachelor of Applied Science in Computer Engineering, University of Toronto.

 

Marwan Aladdin, Co-founder & COO

Marwan Aladdin is a serial entrepreneur, engineer, and published author. Being a coder since the age of 11, he has founded  and grew successful technology ventures with global reach, including: CoursePeer Inc., ArabCode.org, Kula Technologies Inc.,  Angstron Technologies Inc. and others, spanning the fields of education technology, food ordering technology, software  development consulting and Hyperloop (transportation).

 

The University of Toronto has recognized Marwan among its top researchers in its Annual Research Report. Marwan has  played a vital role in establishing the startup incubation system at the University of Toronto.

 

Marwan’s work has been featured at various reputable publications, including the Harvard Business Review, Deloitte reports,  and Dubai School of Government’s Social Media report, and his ventures have been endorsed by government and business  leaders such as Justin Trudeau (Canada’s Prime Minister), Omar Hamoui (Investment Partner at Sequoia Capital; Former  President, Mobile Ads at Google Inc.; Founder of AdMob), Fadi Ghandour (Founder of ARAMEX and Executive Chairman of  Wamda Capital), Ahmad Al Shugairi (activist and media figure in the Middle East), Ilse Treurnicht (CEO of MaRS Discovery  District), and Majed Al Suwaidi (Managing Director of Dubai Internet City and Dubai Outsource Zone).

 

Marwan has been invited as a speaker at various international conferences including the MIT Enterprise Forum and the Annual  Conference of the Higher Education Quality Council of Ontario.

 

Education: Bachelor of Applied Science in Computer Engineering, University of Toronto.

 

Ghassan Barazi, Co-founder & President

Ghassan Barazi, a mechanical engineer with a strong entrepreneurial drive, began his career as a business owner in 1989 when  he formed CAD Venture, a company specializing in computer aided design for the automotive industry. In 1991, Ghassan  tapped into the emerging laser technology industry and co-founded The Laser Eye Institute which, by the end of 1998,  evolved into ICON Laser Eye Centres, Inc. ICON quickly became the fastest growing laser vision correction business in the  world, trading on NASDAQ. With a global reach extending across North America and Europe and into South America, ICON  became the world-leader and international provider of Excimer Laser Vision Correction (LVC), growing to 40 centres world-  wide. Ghassan also spent a considerable portion of his career developing highly successful plastic surgery programs for  private and public medical facilities in Detroit and Las Vegas prior to 2008 when he became the President & CEO of CI Pharma, a radiopharmaceutical supply company and Care Imaging Cancer Diagnostic Centre, a privatized cancer diagnostic  imaging company with locations in both Windsor and the Greater Toronto Area.

 

After a lengthy career in medical, Ghassan became fascinated with the franchise industry and saw the opportunity in 2011 to  purchase the Canadian master licenses for SIGN-A-RAMA, the world’s largest sign franchise and Plan Ahead Events, the  world’s largest event management franchise. Both franchises were started by U.S. based United Franchise Group (UFG). Under  Ghassan’s leadership, SIGN-A-RAMA Canada expanded into 44 sign centers. After that successful growth, Ghassan has  divested his interest in SIGN-A-RAMA Canada and has been focusing his attention on the medical endoscopy/GI clinic,  through the acquisition of the Provis-Rudd clinic (founded 1969).

 

Education: Bachelor of Applied Science in Mechanical Engineering, Ryerson University.

 

Dr. Cindy Gordon, Advisor, Strategy

Dr. Cindy Gordon is the Founder and CEO of SalesChoice, an AI SaaS Predictive and Prescriptive Guiding Selling Company.  She is also an expert in SaaS, AI, business innovation, early-stage software commercialization & sales /marketing practices. She has held senior leadership and partnership roles in global B2B Enterprises, including: Accenture, Xerox, Citicorp and  Nortel Networks.

 

In addition, Cindy has also been a founder, VC, an angel and founder in emerging software companies. She is currently  involved in include: Corent Technology, CoursePeer, Kula, LyfeUp, and TouchTown TV. Cindy is also the Founder of Helix  Commerce International Inc., a strategy innovation firm which serviced global B2B clients like: CIBC, Davis and Henderson, IBM, ING, LGS Electronics, MTS Allstream, Rogers and TD.

 

Internationally, she is recognized for her innovation and thought leadership in: SaaS, Collaboration, AI, technology  emergence, with over 13 books in the market. She is also a 2012 recipient of the Governor’s General Award for Innovation.  She is a 2017 recipient of many awards, including the: STARTUPCANADA National Entrepreneurship Award, CATA & E&Y  Sara Kirke Award for Outstanding CEO: Innovation & Community Leadership, and most Creative CEO Award from Insights  Success.  She is also an Advanced Analytics Expert at the International Institute of Advanced Analytics. She is also currently  working on her 14th book on The AI SPLIT: The Perfect World, or The Perfect Storm.

 

With NFPs, Cindy has a very active community track record including current roles as: AI DIRECTORY, Co-Founder, and  Global Chair, CATA (National Media Spokesperson for Innovation, AI, and STEM), Board Director, RSI, and a Mentor for the  Enterprise Sales Forum (ESF).  Past Roles include: Invest CrowdFund  Canada (ICC), National Chair, Women in Technology  (CANWIT, CATA), Founding Member, Toronto Maple Leaf Angels. She has also been a Former Board Director for Nightwood  Theatre, The Bluma Appel St. LawrenceTheatre. She has also been active in the Canadian Cancer and Prostrate Association,  and The United Way.

 

Education: B.Ed. M.EdAdmin (Information Technology & Decision Support Systems), Doctorate (University of Toronto) (Major: Social  Networks and Collaboration Sciences for Innovation Agility).

 

Ziad Hatahet, Advisor, Technology

Ziad Hatahet is a software engineer with experience in both startups as well as large companies. He has built big data  streaming software from the ground up for use in the cybersecurity field of User Entity Behavior Analytics. He has expertise in  performance analysis and optimization as well as systems modeling. He comes from a strong Silicon Valley background  including such places as Exabeam, Google, and Salesforce. In addition, he has held engineering positions at Amazon Seattle  and IBM Canada. His passions lie in the application of modern techniques and practices to build safe, efficient, performant,  and scalable software systems.

 

Education: Masters of Computer Science, University of Toronto, Bachelor of Science in Computer Engineering, University of Sharjah.

 

Dr. Anas Al-Kassem, MD., Trauma & Bariatric Surgeon, Advisor, Medical

Dr. Anas Al-Kassem is a trauma and Bariatric surgeon who practices in Canada. Dr Al-Kassem received his MD in Damascus,  Syria. He then left to Canada and completed his General Surgery training at the University of Ottawa. He did a clinical  fellowship in Trauma at Foothills in Calgary. After showing leadership skills in Trauma, he was offered the position of a Trauma  Team Leader at the Civic Hospital, University of Ottawa. Dr. Al-Kassem extended his surgery skills and expertise by earning a  MIS/Bariatric Surgery fellowship at Baylor College of Medicine in Texas. Dr. Al-Kassem has been active in many humanitarian  organizations. He is a co-founder of the Union of Medical Care and Relief organizations. He is currently the Chairman of the  Union of Syrian Relief Organizations-Canada. Dr. Al-Kassem has initiated the electronic data registry system for trauma  hospitals in Syria and continues to be involved in the surgery missions to support over 80 hospitals in the devastated country.


Salu – Health Gauge

Salu – Health Gauge

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information

Health Gauge

Location: Edmonton, Alberta

Sector: Health

.

Add to Shortlist
Express Interest

Health Gauge is a personal health monitoring and management solution that provides an Artificial Intelligence (AI) & machine-learning (ML) based platform solution and a device (wrist- or card- form options) to support people in tracking, understanding, and managing their health. Health Gauge’s platform allows users to communicate with and share health data with their doctor, health/wellness practitioner, family, and friends.

 

Health Gauge is far more than simply a wearable; it is a solution that provides deeper analysis, and higher accuracy using artificial intelligence and machine learning.  Health Gauge provides greater awareness, insights, and supports, enabling people to address developing or ongoing health problems more actively.

Business Documents

MG cp Summary

1. High-value AI/ML platform base for advanced health solutions R&D – Our company assets provide a world-leading platform using latest generation tools such as TensorFlow as the production base for our unique Neural-Net tools that will support leading-edge R&D and end-user clients.  Our platform tools will provide for an improved way for new machine-learning and AI tools to serve people in ongoing health monitoring and management.

 

2.World class & highly specialized skills in AI & ML development –  The University of Alberta, where all of our core team is trained, is a top-three world leader in creating highly-skilled and valuable resources in AI/ML development, engineering and microelectronics, and health sciences.  Our team is in high demand for our capabilities and getting national and international notice for our work.  We have 2 resources with M.Sc. degrees in advanced AI/ML skills and have augmented that with additional software, engineering, and business skills.

 

3.Strong connections with University of Alberta / Comp.Science, Health Sciences, and Engineering –In 2017, Google’s DeepMind organization made Edmonton, AB it’s first international investment growth location, based on the experience and profile of educators and talent here to serve Google’s growth needs.  Our work taps into the same core asset base but with a core focus on the high value market opportunities in the health sector, advanced research into new AI/ML applications, and IoT development.

 

4.Unique and extendable IP assets with a global market opportunity – The team began to establish its IP/patent stratagem in 2015 and has recently submitted its patent to the Canadian and US patent offices, after a period of development work that extended through 2017.  We are now in a position to undertake additional IP/patent work to grow and further extend our initial patent strategy.

 

5.Strong development partners in advanced software, IoT, manufacturing and health sciences  – Over the past two years we have been meeting with a number of organizations locally and in different parts of the world – meeting with people who share our vision for the future of health monitoring and management, that serve people in ways they’ve never experienced before.  We have established a number of important connections that we feel will help us scale fast and grow our business quickly.

 

6.High profile first client opportunities with AHS, icddr,b and Government of Canada (Military) – The Company is in negotiations with high profile clients in Canada, the United States, and Asia – who want to acquire in the overall Health Gauge product offering.  The high value assets relate to the Company’s key focus and competencies in AI/ML applications, focus on consumer-health interests, and providing latest generation solutions that enhance and support the health system in the use of advanced technologies to serve end-users.

Randy Duguay, CEO, and Co-founder

Randy Duguay has been involved in new solutions development for over twenty-five years and has worked in health solutions development for over fifteen years.  He is a former executive within TELUS Health Solutions (2002 – 2012) and worked with TELUS Communications for 25 year working in telecom engineering, operations, national projects, strategic & corporate strategy, product development, and commercialization.  Randy was one of the first resources in TELUS Health, now Canada’s leading health technology service provider generating now over $750m in annual revenues.

In addition to working with TELUS, Randy also has worked with the University of Alberta as a Commercialization Officer (contracted) on two occasions for special projects in wireless physiological wearables, and in review of an Virtual Reality data centre joint venture.

 

Bruce Matichuk, CTO, and Co-founder

Bruce Matichuk, MSc. has been in the software industry for 25+ years focusing on the application of AI to real world problems. In the 90s, Bruce developed an AI based integration system that was popular with Fortune 500 companies including Liberty Mutual Insurance Company, Holiday Inn, Lockheed Martin and others.

He was one of the founders of Poynt, Canada’s first search engine company, and was a founder in Clinitrust, the first Canadian based secure email and communications platform for doctors and patients. Recently Bruce co-founded Salu Design Group Inc. to enter the personal health monitoring and analytics market. Salu is using AI/ML techniques to measure and analyze biometrics for hypertension management. AI is a passion for Bruce and he regularly speaks on its emergence and impact, and how businesses can use AI for their benefit.